Ambu A/S
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as… Read more
Ambu A/S (AMBFF) - Net Assets
Latest net assets as of June 2025: $5.91 Billion USD
Based on the latest financial reports, Ambu A/S (AMBFF) has net assets worth $5.91 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.40 Billion) and total liabilities ($1.49 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.91 Billion |
| % of Total Assets | 79.84% |
| Annual Growth Rate | 35.01% |
| 5-Year Change | 135.83% |
| 10-Year Change | 439.96% |
| Growth Volatility | 800.79 |
Ambu A/S - Net Assets Trend (2000–2024)
This chart illustrates how Ambu A/S's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ambu A/S (2000–2024)
The table below shows the annual net assets of Ambu A/S from 2000 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | $5.59 Billion | +3.73% |
| 2023-09-30 | $5.39 Billion | +26.57% |
| 2022-09-30 | $4.26 Billion | +7.82% |
| 2021-09-30 | $3.95 Billion | +66.61% |
| 2020-09-30 | $2.37 Billion | +8.71% |
| 2019-09-30 | $2.18 Billion | +15.94% |
| 2018-09-30 | $1.88 Billion | +47.15% |
| 2017-09-30 | $1.28 Billion | +28.93% |
| 2016-09-30 | $992.00 Million | -4.25% |
| 2015-09-30 | $1.04 Billion | +21.31% |
| 2014-09-30 | $854.00 Million | +28.04% |
| 2013-09-30 | $667.00 Million | -1.64% |
| 2012-09-30 | $678.11 Million | +16.94% |
| 2011-09-30 | $579.86 Million | +3.25% |
| 2010-09-30 | $561.60 Million | +17.09% |
| 2009-09-30 | $479.62 Million | +6.11% |
| 2008-09-30 | $452.01 Million | +8.09% |
| 2007-09-30 | $418.18 Million | +6.93% |
| 2006-09-30 | $391.07 Million | +12.01% |
| 2005-09-30 | $349.14 Million | +9.06% |
| 2004-09-30 | $320.14 Million | +8.85% |
| 2003-09-30 | $294.12 Million | +3.58% |
| 2002-09-30 | $283.94 Million | +4024.07% |
| 2001-09-30 | $6.89 Million | +65.60% |
| 2000-09-30 | $4.16 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ambu A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 521200000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $5.21 Billion | 93.17% |
| Common Stock | $135.00 Million | 2.41% |
| Other Comprehensive Income | $145.00 Million | 2.59% |
| Other Components | $102.00 Million | 1.82% |
| Total Equity | $5.59 Billion | 100.00% |
Ambu A/S Competitors by Market Cap
The table below lists competitors of Ambu A/S ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ALLEGRO MICROSYS. DL-01
F:6V5
|
$3.41 Billion |
|
Northland Power Inc.
PINK:NPIFF
|
$3.41 Billion |
|
Allreal Holding
SW:ALLN
|
$3.41 Billion |
|
Group 1 Automotive Inc
NYSE:GPI
|
$3.41 Billion |
|
Shenzhen O-Film Tech Co Ltd
SHE:002456
|
$3.40 Billion |
|
COUSINS PTIES INC. DL 1
F:CPZ1
|
$3.40 Billion |
|
China Taiping Insurance Holdings Company Limited
F:HIUC
|
$3.40 Billion |
|
Umicore S.A.
BR:UMI
|
$3.40 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ambu A/S's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,393,000,000 to 5,594,000,000, a change of 201,000,000 (3.7%).
- Net income of 235,000,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 66,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $235.00 Million | +4.2% |
| Other Comprehensive Income | $-66.00 Million | -1.18% |
| Other Changes | $32.00 Million | +0.57% |
| Total Change | $- | 3.73% |
Book Value vs Market Value Analysis
This analysis compares Ambu A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.95x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 11.27x to 0.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-09-30 | $1.77 | $19.90 | x |
| 2003-09-30 | $1.83 | $19.90 | x |
| 2004-09-30 | $1.93 | $19.90 | x |
| 2005-09-30 | $1.48 | $19.90 | x |
| 2006-09-30 | $1.67 | $19.90 | x |
| 2007-09-30 | $1.77 | $19.90 | x |
| 2008-09-30 | $1.92 | $19.90 | x |
| 2009-09-30 | $2.03 | $19.90 | x |
| 2010-09-30 | $2.37 | $19.90 | x |
| 2011-09-30 | $2.44 | $19.90 | x |
| 2012-09-30 | $2.83 | $19.90 | x |
| 2013-09-30 | $2.83 | $19.90 | x |
| 2014-09-30 | $3.52 | $19.90 | x |
| 2015-09-30 | $4.19 | $19.90 | x |
| 2016-09-30 | $4.07 | $19.90 | x |
| 2017-09-30 | $5.26 | $19.90 | x |
| 2018-09-30 | $7.60 | $19.90 | x |
| 2019-09-30 | $8.82 | $19.90 | x |
| 2020-09-30 | $9.57 | $19.90 | x |
| 2021-09-30 | $15.61 | $19.90 | x |
| 2022-09-30 | $16.75 | $19.90 | x |
| 2023-09-30 | $20.69 | $19.90 | x |
| 2024-09-30 | $20.97 | $19.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ambu A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.36%
- • Asset Turnover: 0.75x
- • Equity Multiplier: 1.28x
- Recent ROE (4.20%) is below the historical average (10.81%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 0.00% | 0.00% | 0.00x | 1.21x | $-415.77K |
| 2001 | 0.00% | 0.00% | 0.00x | 1.20x | $-688.51K |
| 2002 | 5.28% | 2.61% | 1.02x | 1.98x | $-13.41 Million |
| 2003 | 8.84% | 4.59% | 1.02x | 1.89x | $-3.40 Million |
| 2004 | 10.40% | 5.47% | 1.03x | 1.85x | $1.27 Million |
| 2005 | 10.80% | 5.76% | 0.99x | 1.88x | $2.78 Million |
| 2006 | 12.38% | 6.76% | 1.06x | 1.73x | $9.31 Million |
| 2007 | 10.23% | 5.98% | 1.05x | 1.63x | $959.10K |
| 2008 | 11.06% | 6.38% | 1.07x | 1.62x | $4.81 Million |
| 2009 | 11.63% | 6.36% | 1.12x | 1.63x | $7.80 Million |
| 2010 | 14.97% | 8.94% | 1.07x | 1.56x | $27.90 Million |
| 2011 | 11.94% | 7.04% | 1.11x | 1.53x | $11.23 Million |
| 2012 | 16.22% | 10.52% | 1.08x | 1.42x | $42.19 Million |
| 2013 | 7.20% | 3.47% | 0.73x | 2.84x | $-18.70 Million |
| 2014 | 17.68% | 9.53% | 0.77x | 2.40x | $65.60 Million |
| 2015 | 14.67% | 8.05% | 0.84x | 2.18x | $48.40 Million |
| 2016 | 25.20% | 12.00% | 0.88x | 2.39x | $150.80 Million |
| 2017 | 23.53% | 12.78% | 0.94x | 1.95x | $173.10 Million |
| 2018 | 17.91% | 12.93% | 0.62x | 2.25x | $148.80 Million |
| 2019 | 14.53% | 11.24% | 0.62x | 2.09x | $98.80 Million |
| 2020 | 10.16% | 6.76% | 0.72x | 2.08x | $3.80 Million |
| 2021 | 6.25% | 6.15% | 0.70x | 1.45x | $-148.20 Million |
| 2022 | 2.18% | 2.09% | 0.62x | 1.69x | $-333.10 Million |
| 2023 | 3.12% | 3.52% | 0.70x | 1.27x | $-371.30 Million |
| 2024 | 4.20% | 4.36% | 0.75x | 1.28x | $-324.40 Million |
Industry Comparison
This section compares Ambu A/S's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ambu A/S (AMBFF) | $5.91 Billion | 0.00% | 0.25x | $3.41 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |